Viewing nowCregojeong 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Il Yang Pharmaceuticals Co., Ltd.

MFDS item code 201400380 · Approved 2014.01.28 · Insurance code 641704660
Delays the progression of atherosclerosis by reducing the risk of hypercholesterolemia and cardiovascular disease, and lowers the risk of stroke and myocardial infarction.
This medication is used as an adjunct to diet in patients with primary hypercholesterolemia and mixed dyslipidemia who cannot be controlled with diet and exercise. It is also used in patients with homozygous familial hypercholesterolemia alongside other lipid-lowering therapies to help lower LDL cholesterol levels. In patients with hypercholesterolemia, it reduces total cholesterol and LDL cholesterol to delay the progression of atherosclerosis. It is also used as an adjunct to diet in pediatric patients aged 10 to 17 who meet specific criteria. It helps in the treatment of primary dysbetalipoproteinemia and contributes to reducing the risk of stroke and myocardial infarction in high-risk cardiovascular disease patients with elevated high-sensitivity C-reactive protein levels. Therefore, this drug is effectively used for the reduction of hypercholesterolemia and cardiovascular disease risk.
Independently of meals, take 5 mg once daily as the initial dose. If a greater reduction in LDL cholesterol is needed, adjust to maintenance doses, which are generally calibrated at 10 mg once daily. Maintenance doses should be adjusted appropriately based on LDL cholesterol levels, treatment goals, and patient response at intervals of 4 weeks or more, and can be increased to a maximum of 20 mg per day.
For pediatric patients aged 10 to 17 years, the dosage is 5 mg to 20 mg once daily. The dosage should be adjusted according to individual treatment goals, with adjustments made after 4 weeks or more.
This medication should not be used in certain patients. For instance, patients who have an allergy to any component of this drug or have severely impaired liver function should avoid its use. Additionally, patients with muscle disorders, severe kidney disease, or those who are pregnant or breastfeeding should not use this medication. Women of childbearing potential should use adequate contraception to minimize the possibility of pregnancy and can only use it when fully aware of the risks to the fetus. This drug has the potential to cause muscle damage, thus, caution is needed in patients with moderate to severe impaired kidney function, hypothyroidism, personal history of genetic muscle disorders, alcoholics, individuals of certain races (Asian descent), and when combined with other specific medications. It contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. It is important to regularly monitor liver function and muscle condition during treatment. If symptoms such as muscle pain, weakness, fatigue, or fever occur, medical personnel should be notified immediately. Also, this medication can interact with several other drugs, so if currently taking any other medication, it is essential to notify the healthcare provider, especially when combining with specific antivirals, immunosuppressants, and fibrate medications. Pregnant or breastfeeding women should not use this medication, and women who may become pregnant must use appropriate contraception. In the case of overdose, no specific antidote exists, and treatment should be symptomatic along with liver and muscle function tests. The effects of this drug on driving or operating machinery are unclear, but caution is required as dizziness may occur. Finally, this medication may rarely produce serious side effects such as severe skin reactions, liver dysfunction, or muscle damage, so if symptoms arise, discontinue use immediately and consult medical personnel.
Allergic reactions including urticaria and angioedema, liver dysfunction (jaundice), rhabdomyolysis, severe muscle weakness, ocular muscle weakness, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), acute renal failure, oliguria, thrombocytopenia, fatal and non-fatal liver failure, cough and dyspnea (respiratory issues), severe skin adverse reactions, immune-mediated necrotizing myopathy.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1°C and 30°C. This will help maintain the medication's efficacy and safety over time.
Pink round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Il Yang Pharmaceuticals Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.